Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03254888 | Autophagy Bladder Cancer | unknown | — | 150 | Assiut UniversityOTHER | 1 | Jul 8, 2020 | clinicaltrials |
| NCT04256616 | Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer(ICH-MIM-01) | unknown | — | 110 | Istituto Clinico HumanitasOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT04406168 | Assessment of Urinary Diversions Outcomes Post Radical Cystectomy in Asyut University Urology Hospital | unknown | — | 40 | Assiut UniversityOTHER | 1 | May 28, 2020 | clinicaltrials |
| NCT04385316 | Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy | unknown | — | 3 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)(POUT) | unknown | Phase 3 | 261 | Institute of Cancer Research, United KingdomOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer(CALIBER) | unknown | Phase 2 | 82 | Institute of Cancer Research, United KingdomOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT04295967 | Vasculogenic Mimicry in Urothelial Carcinoma | unknown | — | 70 | Assiut UniversityOTHER | 0 | Mar 5, 2020 | clinicaltrials |
| NCT04264936 | A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer | unknown | Phase 1 / Phase 2 | 36 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03522155 | Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies | unknown | N/A | 136 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT04245618 | Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer | unknown | — | 50 | Assiut UniversityOTHER | 0 | Jan 30, 2020 | clinicaltrials |
| NCT04228198 | Protocol of the Italian Radical Cystectomy Registry | unknown | — | 1,000 | University of Roma La SapienzaOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT03739177 | Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients | unknown | — | 150 | Animated Dynamics, Inc.INDUSTRY | 1 | Jan 13, 2020 | clinicaltrials |
| NCT04223063 | Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study | unknown | N/A | 20 | Ross MasonOTHER | 0 | Jan 10, 2020 | clinicaltrials |
| NCT01447199 | The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) | unknown | — | 2,000 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT04144270 | The Importance of Muscle Function in Patients With Disseminated Bladder Cancer | unknown | — | 30 | Rigshospitalet, DenmarkOTHER | 1 | Nov 20, 2019 | clinicaltrials |
| NCT04148677 | Protoves M1® Syrup in Controlling Adverse Event During HIVEC® Instillations | unknown | — | 100 | Cardarelli HospitalOTHER | 0 | Nov 1, 2019 | clinicaltrials |
| NCT04129606 | Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy(TURBT-BP) | unknown | N/A | 300 | Abdelwahab HashemOTHER | 1 | Oct 17, 2019 | clinicaltrials |
| NCT04060459 | Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 50 | Third Military Medical UniversityOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT03673202 | The Cxbladder Rule-out of Recurrent Urothelial Carcinoma | unknown | — | 300 | London Health Sciences CentreOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT02292914 | Prospective Analysis of Robot-Assisted Surgery | unknown | N/A | 1,120 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT04029948 | Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours | unknown | N/A | 100 | Mansoura UniversityOTHER | 1 | Jul 26, 2019 | clinicaltrials |
| NCT03998371 | Application of UCAD for Diagnosing Urothelial Carcinoma. | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT03982797 | Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis | unknown | Phase 2 | 306 | Biofabri, S.LINDUSTRY | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03973307 | UroX Biomarker Bladder Cancer Study | unknown | — | 100 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Jun 4, 2019 | clinicaltrials |
| NCT03122964 | Multi Institutional Study in Patient Presenting With Hematuria | unknown | — | 1,148 | MDx HealthINDUSTRY | 1 | Mar 6, 2019 | clinicaltrials |
| NCT03831321 | The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy | unknown | Phase 4 | 144 | Taha UçarOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03796299 | Expression of MCM5 in Urine in Patients With Urothelial Cancers | unknown | — | 180 | Medical University of WarsawOTHER | 1 | Jan 8, 2019 | clinicaltrials |
| NCT03790384 | Sequential Combination Therapy in Bladder Cancer(MITOBCG) | unknown | Phase 4 | 140 | Azienda Ospedaliera "Sant'Andrea"OTHER | 0 | Dec 31, 2018 | clinicaltrials |
| NCT03756207 | Multidisciplinary Bladder-preservation Therapy for Bladder Cancer | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Nov 28, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03676946 | A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma | unknown | Phase 1 / Phase 2 | 15 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Sep 26, 2018 | clinicaltrials |
| NCT03577132 | The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer | unknown | N/A | 20 | Seoul National University HospitalOTHER | 0 | Jul 31, 2018 | clinicaltrials |
| NCT03597087 | The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study | unknown | N/A | 289 | Seoul National University HospitalOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT03563443 | Genomic Imprinting Testing for Diagnosis of Bladder Cancer | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT02805608 | uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT02841904 | The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia | unknown | N/A | 189 | Herlev HospitalOTHER | 1 | Mar 6, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03427034 | Assessment of BladderLight SurvEILlance(ABSEIL) | unknown | Phase 2 / Phase 3 | 2,100 | Cambridge University Hospitals NHS Foundation TrustOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT03409029 | A Study Using MRI To Assess Bladder Motion During Radiotherapy | unknown | N/A | 20 | The Christie NHS Foundation TrustOTHER | 0 | Jan 30, 2018 | clinicaltrials |
| NCT03148158 | Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident | unknown | — | 300 | Mansoura UniversityOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03209206 | The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence | unknown | Phase 2 | 84 | Seoul National University HospitalOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03347045 | Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care(TPC-RCT) | unknown | N/A | 50 | Jason MartynOTHER | 0 | Nov 20, 2017 | clinicaltrials |
| NCT03331705 | Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures | unknown | — | 30 | UroSee CorporationINDUSTRY | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02886026 | Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors(LaserIII) | unknown | N/A | 248 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Nov 1, 2017 | clinicaltrials |
| NCT02760953 | TURBt With Adjuvant Cryoablation to Treat Bladder Cancer | unknown | N/A | 150 | Huashan HospitalOTHER | 0 | Oct 19, 2017 | clinicaltrials |
| NCT02228330 | Prospective Clinical Trial - Obturator Reflex Predictors and Blockage | unknown | N/A | 50 | Rabin Medical CenterOTHER | 1 | Oct 17, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jul 8, 2020source: clinicaltrials